Caitong International Asset Management Co., LTD Iovance Biotherapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 168 shares of IOVA stock, worth $283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168
Previous 24,131
99.3%
Holding current value
$283
Previous $179 Million
99.69%
% of portfolio
0.0%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$46.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$41.3 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$35.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$21.5 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$18.7 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $267M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...